OLEA 105 - MeDAL | Breast
metastatic diagnostics, access & literacy | breast cancers
Status
MeDAL | Breast is actively recruiting the OLEA working group. The initiative anticipates finalize its scope in June 2023.
Click below to inquire about OLEA 105 - MeDAL | Breast.
Objectives
improve the ability for metastatic breast cancer patients to ask for biomarker testing through a tailored and co-created digital literacy intervention
assess impact of biomarker literacy program on loved ones of patients
Digital Co-Creation
MeDAL | Breast will improve optimize the learn module for breast cancer patients and their loved ones to educate on biomarker literacy. Following deep listening sessions, patient and caregiver working group participants will co-create the biomarker learning journey on myRabble in an effort to improve shared decision making.
WORKING GROUP:
OLEA 105 - MeDAL | Breast
-
Medical Lead - Open
partner with patient advocacy and alliance mgmt to oversee the conduct the development, implementation, and publications for OLEA 102
-
Patient Lead - Open
local patient advocacy organization which partners with medical and alliance mgmt to oversee the conduct, development, implementation, and publications for OLEA 102
-
Community Member - Open
partnering organization which extends community participation of the initiative to achieve sustainable benefit for the community as a whole
Join the effort
ABCD | Memphis is actively seeking sponsors and community partners to scale the initiative. Click below to inquire further.
